Eventide Asset Management’s Tandem Diabetes Care TNDM Stock Holding History

Eventide Asset Management’s Portfolio TNDM Stock Details TNDM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-275,000	Closed	-$1.36M	–	148
2018 Q1	$1.36M	Buy	+275,000	New	+$887K	0.06%	123
2017 Q1	–	Sell	-27,500	Closed	-$591K	–	129
2016 Q4	$591K	Hold	27,500	–	–	0.04%	114
2016 Q3	$2.11M	Hold	27,500	–	–	0.13%	97
2016 Q2	$2.07M	Buy	27,500 +11,820	+75%	+$951K	0.13%	98
2016 Q1	$1.37M	Buy	15,680 +150	+1%	+$13.1K	0.08%	107
2015 Q4	$1.83M	Hold	15,530	–	–	0.09%	103
2015 Q3	$1.37M	Hold	15,530	–	–	0.08%	104
2015 Q2	$1.68M	Buy	15,530 +2,560	+20%	+$318K	0.09%	102
2015 Q1	$1.64M	Buy	12,970 +245	+2%	+$31.9K	0.12%	99
2014 Q4	$1.62M	Buy	12,725 +4,725	+59%	+$655K	0.18%	87
2014 Q3	$1.07M	Buy	+8,000	New	+$1.12M	0.15%	90

Other funds holding TNDM

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

FCM

Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Eventide Asset Management's TNDM Position: Q2 2018 in Review

Eventide Asset Management sold out of Tandem Diabetes Care (TNDM) in Q2 2018, closing a stake of 275,000 shares — an estimated $1.36M sold.

Eventide Asset Management first reported a position in TNDM in Q3 2014 and held it in 11 quarters. The position peaked at $2.11M in Q3 2016. 116 funds tracked by Wall St. Rank hold TNDM as of Q2 2018.

Eventide Asset Management reported no remaining Tandem Diabetes Care position as of Q2 2018 after selling out during the quarter.
Eventide Asset Management sold 275,000 Tandem Diabetes Care shares in Q2 2018, an estimated $1.36M.
Eventide Asset Management first reported a position in Tandem Diabetes Care in Q3 2014 and held it in 11 quarters.
Eventide Asset Management's Tandem Diabetes Care position peaked at $2.11M in Q3 2016.
116 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q2 2018.

Based on Eventide Asset Management's 13F filing for Q2 2018, filed 14 Aug 2018.